After struggling to greenlight an early Johnson & Johnson vaccination program for healthcare workers in South Africa, the country briefly banned the vaccine due to cases of rare blood clots. However, South Africa has decided to resume vaccination, as have regulators in European Union. The African nation is yet to report any cases of blood clots.